BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 11117247)

  • 1. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
    Smit W; de Waart DR; Struijk DG; Krediet RT
    Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal transport characteristics with glucose polymer based dialysate.
    Ho-dac-Pannekeet MM; Schouten N; Langendijk MJ; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1996 Sep; 50(3):979-86. PubMed ID: 8872974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal fluid transport in CAPD patients with different transport rates of small solutes.
    Sobiecka D; Waniewski J; Weryński A; Lindholm B
    Perit Dial Int; 2004; 24(3):240-51. PubMed ID: 15185772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid and solute transport in CAPD patients before and after permanent loss of ultrafiltration capacity.
    Waniewski J; Sobiecka D; Debowska M; Heimbürger O; Weryński A; Lindholm B
    Int J Artif Organs; 2005 Oct; 28(10):976-86. PubMed ID: 16288435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrafiltration and solute kinetics using low sodium peritoneal dialysate.
    Leypoldt JK; Charney DI; Cheung AK; Naprestek CL; Akin BH; Shockley TR
    Kidney Int; 1995 Dec; 48(6):1959-66. PubMed ID: 8587258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between 1.36% and 3.86% glucose dialysis solution for the assessment of peritoneal membrane function.
    Smit W; Langedijk MJ; Schouten N; van den Berg N; Struijk DG; Krediet RT
    Perit Dial Int; 2000; 20(6):734-41. PubMed ID: 11216568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative description of solute and fluid transport during peritoneal dialysis.
    Heimbürger O; Waniewski J; Werynski A; Lindholm B
    Kidney Int; 1992 May; 41(5):1320-32. PubMed ID: 1614047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
    Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD?
    Monquil MC; Imholz AL; Struijk DG; Krediet RT
    Perit Dial Int; 1995; 15(1):42-8. PubMed ID: 7734560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High peritoneal residual volume decreases the efficiency of peritoneal dialysis.
    Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
    Kidney Int; 1999 May; 55(5):2040-8. PubMed ID: 10231469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal transport during dialysis with amino acid-based solutions.
    Park MS; Heimbürger O; Bergström J; Waniewski J; Werynski A; Lindholm B
    Perit Dial Int; 1993; 13(4):280-8. PubMed ID: 8241328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The standard peritoneal permeability analysis in the rabbit: a longitudinal model for peritoneal dialysis.
    Zweers MM; Douma CE; de Waart DR; van der Wardt AB; Ho-dac-Pannekeet MM; Krediet RT; Struijk DG
    Perit Dial Int; 1999; 19(1):56-64. PubMed ID: 10201342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluid and solute transport in CAPD patients using ultralow sodium dialysate.
    Imholz AL; Koomen GC; Struijk DG; Arisz L; Krediet RT
    Kidney Int; 1994 Aug; 46(2):333-40. PubMed ID: 7967344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD.
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1997 Jun; 51(6):1885-92. PubMed ID: 9186879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluid and solute transport using different sodium concentrations in peritoneal dialysis solutions.
    Cheng HH; Wang T; Heimbürger O; Bergström J; Lindholm B
    Perit Dial Int; 2001; 21(1):65-71. PubMed ID: 11280498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal function and assessment of reference values using a 3.86% glucose solution.
    Smit W; van Dijk P; Langedijk MJ; Schouten N; van den Berg N; Struijk DG; Krediet RT
    Perit Dial Int; 2003; 23(5):440-9. PubMed ID: 14604195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Threefold peritoneal test of osmotic conductance, ultrafiltration efficiency, and fluid absorption.
    Waniewski J; Paniagua R; Stachowska-Pietka J; Ventura MD; Ávila-Díaz M; Prado-Uribe C; Mora C; García-López E; Lindholm B
    Perit Dial Int; 2013; 33(4):419-25. PubMed ID: 23378471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study.
    Plum J; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
    Perit Dial Int; 1999; 19(5):418-28. PubMed ID: 11379854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.